Entheon Biomedical Announces EEG Patent Application & Provides Research Update
Ryan Allway December 16th, 2021 Psychedelics Vancouver, British Columbia–(Newsfile Corp. – December 16, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“), a biomedical company focused on the research and development of psychedelic drugs and leading-edge biomarkers to provide personalized treatment of addiction... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )